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The mortality of acute lung injury and acute respiratory distress syndrome (ALI/ARDS) remains high and eﬀorts for prevention
and treatments have shown little improvement over the past decades. The present study investigated the eﬃcacy and mechanism
of leukocytapheresis (LCAP) to partially eliminate peripheral neutrophils and attenuate lipopolysaccharide (LPS)-induced lung
injury in dogs. A total of 24 healthy male mongrel dogs were enrolled and randomly divided into LPS, LCAP and LCAP-sham
groups. All animals were injected with LPS to induce endotoxemia. The serum levels of leucocytes, neutrophil elastase, arterial
blood gas, nuclear factor-kappa B (NF-κB) subunit p65 in lung tissues were measured. The histopathology and parenchyma
apoptosis of lung tissues were examined. We found that 7, 3, and 7 animals in the LPS, LCAP, and sham-LCAPgroups,respectively,
developed ALI 36h after LPS infusion. The levels of NF-κB p65 in lung tissue, neutrophils and elastase in blood, decreased
signiﬁcantly following LCAP. LCAP also alleviated apoptosis, and NF-κB p65 in lung tissues. Collectively, our results show that
partial removal of leucocytes from peripheral blood decreases elastase level in serum. This, in turn, attenuates lung injuries and
may potentially decrease the incidence of ALI.
1.Introduction
Acute lung injury (ALI) and acute respiratory distress syn-
drome (ARDS) are characterized by increased permeability
of the alveolar-capillary barrier, resulting in an inﬂux of
protein-rich edematous ﬂuid and a consequent impairment
in arterial oxygenation. Mortality remains high in spite
of sophisticated intensive care [1–4]a th i g hc o s t[ 5]a n d
improved strategies in prevention and treatments [6, 7].
Thus, there is an urgent need to explore potential novel
preventative and therapeutic strategies for patients with, or
at high risk of developing, ALI/ARDS.
It is generally accepted that most forms of ALI involve
lung neutrophil entrapment and activation, as well as
neutrophil-mediated pulmonary injury [8–10]. Various pro-
teinaceous inﬂammatory mediators either directly or indi-
rectly induce lung injury through activation of neutrophils
and induction of cytotoxic molecules. This is especially true
of the serine protease neutrophil elastase (NE) and oxidants
produced by neutrophils in pulmonary and circulating pools
[11].
Leukocytosis, a condition characterized by an elevated
number of leukocytes in the blood, is the prominent
feature of bacteritic sepsis. In patients with sepsis-related
ALI, signiﬁcantly higher neutrophil counts (10-fold) in the
bronchoalveolar lavage ﬂuid (BALF) were consistently noted
in non-survivors as compared to survivors, 7–14d after
intubation [12]. It is well known that neutrophils in the
BALF or lung tissue are recruited from peripheral blood
during the development of lung injury. Thus, inhibition
and partial elimination of peripheral neutrophils may be a
potential prophylactic or treatment strategy for endotoxin-
induced ALI/ARDS.
Several in vivo studies have demonstrated that inhibi-
tion of peripheral neutrophils could attenuate neutrophil-
mediated lung injury [10, 13]. One report showed similar2 Mediators of Inﬂammation
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Figure 1: Schematic summary of LCAP and sham-LCAP proce-
dures. LCAP was performed by an automated continuous-ﬂow
blood cell separator. The parameters were set based on the targets.
The total separated cycles were adjusted according to the eﬃciency
of separation during the LCAP process. The sham-LCAP group
underwent all the same procedures as the LCAP group except for
removal of the leucocytes, carried out by continuous reinfusion of
the separated leucocytes in the storage bag.
result from removal of peripheral macrophages [14]. While
such interventions with chemicals targeting all neutrophils
appeared to reduce inﬂammation, most of these results were
from small rodents [10, 15]. We hypothesize that partial
removal of peripheral leucocytes, and in particular neu-
trophils, can alleviate ALI. The present study utilized LCAP
toinvestigatetheeﬀectofdecreasedperipheralneutrophilsin
preventingALIinaninducedendotoxemiadogmodelandto
explore the underlying mechanisms.
2.MaterialsandMethods
2.1. Animals. The Experimental Animal Care and Use
Committees, Third Military Medical University, Chongqing,
China, reviewed and approved the animal use and care
protocols of this study. Twenty-four dogs (15–20kg) from
the Animal Center of the university were equally divided into
LPS, LCAP, and LCAP-sham groups. Animals were housed at
room temperature with a 12-h/12-h light/dark cycle for one
w e e ka n dd e p r i v e do ff o o df o r1 2hb e f o r es u r g e r y .
2.2. Anesthesia and Surgery. Animals received general
anesthesia induced by intravenous injection of ketamine
(25mg/kg body weight) and xylazine (7mg/kg). Sodium
pentobarbital (1mg/kg) was intermittently administrated to
maintain anesthesia. All surgery procedures were performed
in an animal surgery facility under sterile conditions.
After tracheotomy and intubation, mechanical venti-
lation was conducted using SIMV with Tv 10mL/kg, 30
breathes/min, inspiratory oxygen fraction 29%, and PEEP
3cm H 2O (Newport 200, USA). The distal end piece of
the infusion set was inserted into the left jugular and right
femoral veins to prepare for connection to a blood cell
separator(COM.TEC,Fresenius,Germany).Aheparin-ﬁlled
catheter was inserted into the right femoral artery for mon-
itoring blood pressure through a pressure transducer and
collecting blood samples. The parameters were continuously
recorded with PowerLab/16SP (AD Instruments) for data
acquisition.
2.3. Endotoxemia. Following anesthesia, monitoring, venti-
lation, and vessel preparation, all animals were intravenously
injected with LPS (2mg/kg Escherichia coli O55:B5, Sigma,
USA) dissolved in 100mL normal saline [16]f o r3 0m i nt o
induce endotoxemia.
2.4. Leukocytapheresis (LCAP). LCAP was performed by
an automated continuous-ﬂow blood cell separator after
stable hemodynamics were attained. The mononuclear cell
program was selected to separate peripheral leucocytes. The
blood ﬂow rate and total number of separation cycles were
set according to the animal’s gender, body weight, height,
hematocrit level and targeted peripheral leucocyte count,
and the total separation cycles were adjusted as needed. The
counts of leukocytes and neutrophils in the periphery and
collected storage bag were sampled to estimate the eﬃciency
of separation during the LCAP process.
The sham-LCAP group did not undergo removal of the
leucocytes,carried outbycontinuous reinfusion ofseparated
leucocytes (Figure 1). The time point 16h selected for LCAP
was based on our preliminary data (n = 10, not shown)
that the peripheral leucocyte count recuperated to the basal
value (8.36 to 16.4 × 109 /L) about 16h following the LPS
challenge, and the lower limit was treated as target value (8.0
× 109 /L).
2.5. Blood Samples. After anesthesia, as a basal value or at
other time points, 5mL of blood was collected, a portion
of which was used for the leucocyte and neutrophil counts
and arterial blood gas analysis (I-STAT, Abbott, USA).
The remaining was centrifuged at 1500×g for 10min; the
supernatantwascollectedandstoredat −80◦Cforotheruses.
Each animal received a chest X-ray when the oxygenation
index was <300mmHg.
2.6. Bronchoalveolar Lavage and Lung Tissue Preparation.
The animals were euthanized at 36h under anesthesia
followed by BALF, tracheostomy, and en bloc isolation of
the lungs. Brieﬂy, the right inferior lung was inserted with
a catheter and rinsed with 20mL saline for collecting BALF.
After centrifugation, the pellet in BALF was resuspended
and the neutrophil was counted with a LH500 hematology
analyzer (Beckman Coulter, USA) under Wright’s stain.
The cell-free supernatant was stored at −80◦C for other
assays. Lung tissues from the left-lower lung lobe were
dissected into pieces, ﬁxed in 4% paraformaldehyde for
general pathological examinations, or frozen at −80◦Cf o r
assays of malondialdehyde (MDA), p65, TNF-α,w e t / d r y
ratio, and cell apoptosis in situ.Mediators of Inﬂammation 3
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Figure 2: The eﬀect of LPS and LCAP on WBC and PMN counts and NE level in periphery. The numbers of WBCs and PMNs collected
from the right femoral artery at indicated time periods after LPS injection were detected using the Digicell 500 cell counter and enumerated
withGiemsa-WrightStain.TheanimalsintheLPSgroupunderwentonlyLPSinjectionatthezerotimepoint.ExceptforLPSadministration,
the animals in the sham-LCAP group underwent a sham-LCAP procedure (carried out by reinfusion of the end-products collected in a
storage bag) at time point 16 h, for up to 4 h. and the animals in the LCAP group underwent both LPS injection and LCAP at corresponding
time points. (a) WBC counts following the LPS injection and LCAP (/sham-LCAP). (b) PMN counts following LPS injection and LCAP
(/sham-LCAP). (c) The level of NE following LPS injection and LCAP (/sham-LCAP). ∗indicates signiﬁcant diﬀerence among the LCAP,
LPS, and sham-LCAP groups at the indicated time (∗P<0.05; ∗∗P<0.01). #indicates signiﬁcant diﬀerence between the LCAP and LPS
groups at the indicated time (P<0.05).
2.7. Myeloperoxidase and NE Levels in BALF and Blood
Serum. M y e l o p e r o x i d a s ea n dN El e v e l si ns e r u ma n dB A L F
were assayed with ELISA kits (R&D, USA) according to
the manufacturer’s instructions, to determine neutrophil
accumulation and NE release.
2.8. Protein Content in BALF, Protein Expression of p65,
TNF-α and MDA in Lung Tissues. The total protein in
BALF was measured by the method of Bradford according
to the manufacturer’s protocol (Bio-Rad, USA). Tissue
samples from lung were homogenized in PBS containing a
protease inhibitor cocktail (Applygen, China) and nuclear
fractionation was performed using an EZ nuclei isolation kit
(Applygen, China) according to the manufacturer’s protocol.
The supernatant was collected and mixed. The production of
p65 and TNF-α were measured using ELISA kits according
to the manufacturer’s protocol (R&D, USA). Optical density
wasreadat450nmbyaDR5000spectrophotometer(1Hach,
USA).
The detection of MDA in parenchyma was performed
based on the manufacturer’s instructions (Nanjing KeyGen,4 Mediators of Inﬂammation
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Figure 3: The eﬀect of LCAP on the average levels of PMN and NE in three groups. The numbers of PMN in the right femoral artery were
counted at the indicated time period using the Digicell 500 cell counter (a), and the mean levels of NE in sera at the same time periods were
determined by ELISA kits (R&D, USA) according to the manufacturer’s instructions (b). ∗indicates signiﬁcant diﬀerence between the LCAP
and the sham-LCAP groups (P<0.05). ∗∗indicates signiﬁcant diﬀerence between the LCAP and the LPS groups (P<0.01).
China). Optical density was read at 532nm with the
spectrophotometer. The values of MDA were expressed as
nM.
2.9. Water Content in Lung Tissue. The incised section of
lung tissue was weighed immediately and dried at 96◦Ci na n
oven for 24h and weighed again. The volume of lung tissue
edema was measured by calculating the wet/dry weight ratio.
2.10. Lung Pathological Changes and Polymorphonuclear
Neutrophil (PMN) Count in Lung Tissue. Tissues ﬁxed in 4%
paraformaldehyde were dehydrated in an ascending series of
ethyl alcohol, cleared in xylene, and embedded in paraﬃn.
Paraﬃns e c t i o n sw e r ec u ta t1 5μmo nar o t a r ym i c r o t o m e ,
mounted on slides, stained with hematoxylin-eosin (H&E).
Ten ﬁelds of each section were randomly selected to count
the numbers of PMN cells.
2.11. TUNEL Assay and H&E Stain in Lung Tissues. The ter-
minal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) assay was performed using an In Situ Cell Death
Detection Kit, Peroxidase (Nanjing KeyGen, Nanjing, China)
according to the instructions from the manufacturer. Ten
ﬁelds of each section were randomly selected to count the
numbers of positive apoptotic cells.
2.12. Statistical Analyses. All values are expressed as the
mean ± standard error (SE). The data were analyzed with
Statistical Products and Service Solutions (SPSS) 13.0 for
Windows software. Comparisons among the groups at the
corresponding time points were performed using Student’s
t-test. The average levels of leukocytes, PMNs, and NE
were calculated, and the comparisons among groups were
performed by one-way ANOVA. Incidences of ALI in groups
were analyzed with the chi-square test. Probability (P)v a l u e s
less than 0.05 (P<0.05) were considered statistically
signiﬁcant.
3. Results
3.1. Incidence of ALI. Diagnoses for ALI and ARDS followed
the criteria set by the American-European Consensus Con-
ference of 1994 [12]. Accordingly, 7 animals in each of the
LPS and sham-LCAP groups, and 3 in the LCAP group
developed ALI (P<0.05, LCAP versus LPS and sham-LCAP
group). No ARDS was found in any of the groups.
3.2. The Numbers of Leucocytes and Neutrophils in Blood,
BALF, and Lung Tissues. T h ec o u n t so fl e u c o c y t e sa n d
neutrophils in the periphery decreased rapidly following the
injection of LPS, then increased slowly and returned to basal
values about 16h after injection, and afterward gradually
increased further (Figures 2(a) and 2(b)). The counts of
peripheral leucocytes and neutrophils in the LCAP group
were signiﬁcantly reduced at 20 and 24h compared to the
LPS or sham-LCAP groups (P<0.01 or P<0.05, resp.). The
level of NE increased steadily following the LPS challenge,
while LCAP slowed the ascending trend compared to the LPS
and sham-LCAP groups (Figure 2(c)).
The average count of neutrophils in the LCAP group was
statistically lower than in the LPS or the sham-LCAP groups
(P<0.05 or P<0.01; Figure 3(a)), as were the levels of NE
(Figure 3(b)) in serum. Compared to the other two groups,
the level of p65 (Figure 4(a)) in lung tissues, the wet/dry
ratio of lung (Figure 4(b)), the total protein concentration
in BALF (Figure 4(c)), the percentage of apoptotic cells
in lung parenchyma (Figure 4(d)), and the incidence of
ALI (Figure 4(e)) in the LCAP group was statistically lower
compared to the LPS and sham-LCAP groups. Finally, theMediators of Inﬂammation 5
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Figure 4: The eﬀect of LCAP on p65 protein levels in lung parenchyma, total protein concentration in BALF, wet/dry ratio in lung, and
apoptotic changes in lung tissues. The p65 was examined by ELISA kits, and optical density was read at 450nm (a). The water content of
the tissues from left inferior lung was shown as wet/dry weight ratio (b). The total protein concentration in BALF assayed by methods of
Bradford (c); apoptotic cells (arrow) in left inferior lung parenchyma were detected by TUNEL in situ assay using an In Situ Cell Death
Detection Kit (d); incidence rate of ALI/ARDS was diagnosed according to the criteria for ALI/ARDS by the American-European Consensus
Conference of 1994 (e). The mean levels of PMN counts and NE in the 7 animals without ALI were compared to 17 animals with ALI
(f). ∗indicates signiﬁcant diﬀerence among the LCAP, LPS, and the sham-LCAP groups (∗P<0.05; ∗∗P<0.01); Δ indicates signiﬁcant
diﬀerence among the LCAP, LPS, and sham-LCAP groups (P<0.05).6 Mediators of Inﬂammation
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Figure 5:ThecorrelationbetweenoxygenationindicesandtheaveragelevelsofthePMNcountinperipheryandNEinserum.Wecalculated
the mean levels of PMN in the peripheral blood at indicated time period and showed the correlation between the mean levels of PMN in the
periphery and the oxygenation indices (PaO2/FiO2)a t3 6h( r =− 0.557, P = 0.005) (a). The correlation between the mean levels of NE in
serum and the oxygenation indices at 36 h were examined (r =− 0.575, P = 0.003) (b).
averagelevelsofPMNcountsandNEinanimalswithoutALI
were also lower than in animals with ALI (Figure 4(f)).
In addition, the average levels of PMN and NE in
peripheral blood were inversely correlated with oxygenation
indices at 36h (Figures 5(a) and 5(b)). However, the
numbers of PMNs and the levels of NE in BALF, and the
PMNs, MDA, and TNF-α in lung tissues had no signiﬁcant
diﬀerences among groups (data not shown).
3.3. General Pathological and Apoptotic Changes in Lung
Parenchyma. Lung interstitial edema, hyperemia, and neu-
trophil detention in microvascular exudation in lung inter-
stitial and alveolar spaces were found in all groups after the
LPS challenge. However, relatively minor abnormal lesions
were observed in the LCAP group (Figures 6(a)–6(c)).
The numbers of apoptotic lung parenchyma cells in the
LCAP group were signiﬁcantly lower compared to that in the
LPS and the sham-LCAP groups (P<0.05; Figures 7(a)–
7(c)).
4. Discussion
LCAP has been reported to remove both neutrophils and
other leucocytes [17]. In this study, we focused on removal
of neutrophils and tested their role in the pathogenesis of
ALI. Recent reports showed that ﬁltering leucocytes from
blood could inhibit the systemic inﬂammatory response
[18, 19]. Our results demonstrated that neutrophils in the
periphery played an important role in the development of
ALI in our endotoxemia animal model and that partial
removal of neutrophils decreased NE in serum. In addition,
LCAP was found to aﬀect p65 expression in lung tissues
and the number of apoptotic lung parenchyma cells, all
of which have been strongly linked to ALI/ARDS occur-
rence. Although such interventions might not completely
prevent animals from a descending trend in oxygenation
indices following endotoxemia, the incidence of ALI was
signiﬁcantly lower in the LCAP group than in the LPS
and sham-LCAP groups. Furthermore, ﬁndings in lung
pathology could partially explain the mechanism by which
LCAP prevented the experimental animals from developing
severelunginjuries.Somebiganimals,suchasmongreldogs,
toleratelipopolysaccharidewell,anditwasdiﬃculttoinduce
endotoxemia-associated ALI/ARDS in our preliminary study
by administration of a low dose of LPS. We used LPS at
2mg/kg to induce endotoxemia-associated ALI. Consistent
with this, similar doses of LPS were used in another study
[19]. Nevertheless, the outcome of LCAP on removing
leukocytes was still eﬀective in spite of the huge dose of
LPS used to induce ALI. This could explain why the eﬀects
of removal of leukocytes were relatively moderate and only
visible at two time points.
As one of the most destructive proteases, NE can degrade
key structural elements of connective tissues in endothelial
and epithelial cells, thrombomodulin, and proteoglycans in
basement membrane and lung interstitium [20]. Thus, it is
NE that is mainly responsible for the damage to the alveolar-
capillary barrier. Our result is consistent with the ﬁnding
that inhibition of NE improved the outcome of patients with
ALI/ARDS [21].
By promoting expressions of many downstream inﬂam-
matory factors related to lung damage, activation of NF-
κB has been linked to the pathogenesis of ALI/ARDS [22].
It also induces the apoptosis of lung parenchyma cells andMediators of Inﬂammation 7
x400
(a)
x400
(b)
x400
(c)
Figure 6: The pathologic changes of lung tissues. Lung tissues from the left-lower lobe underwent routine ﬁxation, dehydration, sectioning,
and staining with H&E. General pathological changes of lung tissues were observed by optical microscope. The average neutrophil (arrows)
countswerecalculated in10randomhigh-powerﬁeldspersectionunderphotomicroscope(10 ×40).(a)LPSgroup;(b)sham-LCAPgroup;
(c) LCAP group.
attenuates the apoptosis of neutrophils, thus enhancing the
lung injury process. Our ﬁndings suggested that LCAP could
attenuate lung injury by reducing expression of p65, one of
the key components of NF-κB. This needs to be determined.
The protein content in BALF, the PMN counts and
NE level in serum and BALF, the water content of lung
tissue, MDA and apoptotic changes in lung parenchyma are
important biomarkers relevant to lung injury occurrence.
They act as inﬂammatory mediators in activation of PMNs
andresultindevelopmentofALI/ARDS.Currently,blockade
of these factors in an attempt to reduce ALI/ARDS has
limited success. Also, no dependable therapies are currently
available that can safely and reversibly interrupt PMN
detention, recruitment, and inﬁltration in the lung or inhibit
the production of inﬂammatory mediators, especially NE
and reactive oxygen species. It seems that the appearance of
ALI/ARDS is unavoidable in many cases, including serious
sepsis or trauma. Although LCAP could not completely
reverse the ascending trend of these inﬂammatory factors
after the endotoxin challenge, partial removal of peripheral
PMNs might be a potential therapeutic approach for this
illness.
Moderate increase in PMN plays an important role in
protecting the organism against various insults. ALI/ARDS
is the result of continuous attacks to lung tissues by excessive
inﬂammatorymediators,ofwhichNEisthemostimportant.
We reasoned that ALI/ARDS might occur only when PMN
and NE levels in periphery are raised persistently, rather
than transiently. Our results showed that the mean levels of
PMN and NE were signiﬁcantly lower in the LCAP group
as compared to the LPS and sham-LCAP groups, with the
exception of at 20h and 24h. Also, the mean levels of PMNs
and NE in animals without ALI were signiﬁcantly lower
than those in animals with ALI. This might explain that
the decrease in PMNs and NE for a limited time could
also prevent the animals from developing ALI and implied
that the occurrence of ALI was due to the continuous and
cumulative damages from excessive PMNs and NE in the
periphery. Thus, the interruption of continuous damages
from excessive neutrophils and NE by LCAP may be an
alternative therapeutic strategy.
Although determination of “excessive” leucocytes can be
easily made according to the diagnostic criteria for systemic
inﬂammatory syndrome or sepsis, it seems impossible to8 Mediators of Inﬂammation
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Figure 7: Apoptotic changes in alveolar epithelial and endothelial cells. Frozen tissues from the left inferior lung were routinely sectioned
(20μM), ﬁxed, digested, and incubated in 0.3% H2O2 and methanol and 0.1% Triton X-100. then reacted with TUNEL reaction mixtures,
peroxidase, and DAB substrate solution. The apoptotic cells showed brown nuclei following DAB stain, while the nonapoptotic cells
presented blue nuclei following costain with H&E. The average apoptotic cells were calculated in 10 random high-power ﬁelds per section
under photomicroscope (10 × 40). (a) LPS group; (b) sham-LCAP group; (c) lCAP group. The arrows indicate apoptotic staining in nuclei.
make an acknowledged conclusion regarding the exact level
of neutrophils when faced with a complicated clinical case.
Previous reports suggested that LCAP was safe with few
and minor adverse eﬀects when used for some refractory
autoimmune diseases [23, 24]. Interestingly, the counts of
WBC and PMN decreased rapidly following LPS injection,
which was consistent with an other report [25]. This might
imply that the leukocytes and neutrophils in the periphery
were activated rapidly and adhered to the vascular wall or
were recruited to the target organs (often the lung is the ﬁrst
target). This resulted in a transient decrease in the numbers
of leukocytes in circulation. Increased numbers of leukocytes
and neutrophils were mostly due to the organism mobilizing
the leukocytes in the hemopoietic system and then releasing
them into the circulation. This suggested that an earlier
initiation of leukocyte removal before LPS injection might
further reduce lung injury from the excessive neutrophils
activated by LPS.
The ﬁndings in our endotoxemia model suggest that the
partialremovalofleucocytesandneutrophilsattenuateslung
damage and prevents animals from developing ALI without
signiﬁcantly damaging innate immunity.
Although our ﬁnding is encouraging, it was obtained
from preliminary research only. More studies that include
a larger sample population are needed to conﬁrm this
result.Anadditionalmethodofexclusionofneutrophilsmay
be required. Furthermore, the preventive and therapeutic
eﬃcacies of LCAP in endotoxemia-associated ALI/ARDS
need to be explored further.
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